Salveen Richter
Stock Analyst at Goldman Sachs
(2.38)
# 2,207
Out of 4,827 analysts
213
Total ratings
40.5%
Success rate
-1.42%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $51 → $44 | $3.07 | +1,333.22% | 4 | May 9, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Neutral | $53 → $47 | $35.99 | +30.59% | 4 | May 8, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $15 → $13 | $8.46 | +53.76% | 3 | May 8, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $178 → $100 | $36.73 | +172.26% | 4 | May 7, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $124 → $104 | $59.38 | +75.14% | 1 | May 5, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $37 → $41 | $23.88 | +71.69% | 2 | May 2, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $12 → $9 | $6.10 | +47.54% | 2 | May 2, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $9 → $10 | $9.26 | +7.99% | 11 | May 2, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $917 → $804 | $539.45 | +49.04% | 11 | Apr 30, 2025 | |
| BIIB Biogen | Maintains: Buy | $219 → $197 | $119.05 | +65.48% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $36 → $32 | $17.27 | +85.29% | 8 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $3.03 | +494.06% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $96.49 | -0.51% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $24.78 | +105.81% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $14.50 | +175.86% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $8.20 | +46.34% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $20 | $12.51 | +59.87% | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $59.49 | +17.67% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $198 → $370 | $253.70 | +45.84% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $35.66 | +113.12% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $33 → $37 | $32.70 | +13.15% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $11 | $6.61 | +66.41% | 11 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $27.91 | +89.90% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $269.38 | +29.93% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $431.32 | +29.60% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $5 | $5.00 | +0.10% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $12.27 | -59.25% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.20 | +2,494.14% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $288.66 | -22.05% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $1.30 | +1,592.31% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.41 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $5.05 | +494.06% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $14 | $0.72 | +1,840.13% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $4.44 | +102.70% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $2.13 | +41.18% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $15 → $12 | $17.55 | -31.62% | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $1.87 | +221.72% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $50.12 | -14.21% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $40 → $60 | $3.63 | +1,555.17% | 6 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $1.53 | +30.72% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $7.36 | +1,258.62% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $30 | $0.36 | +8,233.33% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $91.17 | -45.15% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $12.99 | +246.55% | 1 | Mar 17, 2020 |
4D Molecular Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $51 → $44
Current: $3.07
Upside: +1,333.22%
CRISPR Therapeutics AG
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $35.99
Upside: +30.59%
Arcus Biosciences
May 8, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $8.46
Upside: +53.76%
Sarepta Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $178 → $100
Current: $36.73
Upside: +172.26%
BioMarin Pharmaceutical
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $59.38
Upside: +75.14%
Summit Therapeutics
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $23.88
Upside: +71.69%
Amicus Therapeutics
May 2, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $6.10
Upside: +47.54%
Adaptive Biotechnologies
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $9.26
Upside: +7.99%
Regeneron Pharmaceuticals
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $539.45
Upside: +49.04%
Biogen
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $119.05
Upside: +65.48%
Mar 3, 2025
Maintains: Neutral
Price Target: $36 → $32
Current: $17.27
Upside: +85.29%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $3.03
Upside: +494.06%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $96.49
Upside: -0.51%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $24.78
Upside: +105.81%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $14.50
Upside: +175.86%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $8.20
Upside: +46.34%
Dec 12, 2024
Maintains: Neutral
Price Target: $9 → $20
Current: $12.51
Upside: +59.87%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $59.49
Upside: +17.67%
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $253.70
Upside: +45.84%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $35.66
Upside: +113.12%
Aug 2, 2024
Maintains: Sell
Price Target: $33 → $37
Current: $32.70
Upside: +13.15%
Jul 26, 2024
Maintains: Neutral
Price Target: $19 → $11
Current: $6.61
Upside: +66.41%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $27.91
Upside: +89.90%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $269.38
Upside: +29.93%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $431.32
Upside: +29.60%
Sep 13, 2023
Downgrades: Neutral
Price Target: $5
Current: $5.00
Upside: +0.10%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $12.27
Upside: -59.25%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.20
Upside: +2,494.14%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $288.66
Upside: -22.05%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $1.30
Upside: +1,592.31%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.41
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $5.05
Upside: +494.06%
Nov 10, 2022
Maintains: Buy
Price Target: $25 → $14
Current: $0.72
Upside: +1,840.13%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $4.44
Upside: +102.70%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $2.13
Upside: +41.18%
Nov 4, 2022
Downgrades: Sell
Price Target: $15 → $12
Current: $17.55
Upside: -31.62%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $1.87
Upside: +221.72%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $50.12
Upside: -14.21%
Aug 19, 2022
Maintains: Sell
Price Target: $40 → $60
Current: $3.63
Upside: +1,555.17%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $1.53
Upside: +30.72%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $7.36
Upside: +1,258.62%
Mar 4, 2021
Upgrades: Buy
Price Target: $28 → $30
Current: $0.36
Upside: +8,233.33%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $91.17
Upside: -45.15%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $12.99
Upside: +246.55%